batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Big Dreamms for GSK 8 November 2024 After just four patients Pfizer ends LTβR study 6 November 2024 Sana loses its taste for oncology 5 November 2024 Here come the dual-payload ADCs 4 November 2024 SITC 2024 preview – late-breakers for Marengo and Indapta 4 November 2024 EvolveImmune engages AbbVie 1 November 2024 Lilly fans the degrader Embers 30 October 2024 GlycoMimetics gets on the PD-1/VEGF bandwagon 29 October 2024 Load More